| Nanostructured lipid carriers: Promising drug delivery systems for future clinics A Beloqui, MÁ Solinís, A Rodríguez-Gascón, AJ Almeida, V Préat Nanomedicine: Nanotechnology, biology and medicine 12 (1), 143-161, 2016 | 667 | 2016 |
| pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease A Beloqui, R Coco, PB Memvanga, B Ucakar, A des Rieux, V Préat International journal of pharmaceutics 473 (1-2), 203-212, 2014 | 243 | 2014 |
| Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier A Beloqui, MÁ Solinís, AR Gascón, A del Pozo-Rodríguez, A des Rieux, ... Journal of Controlled Release 166 (2), 115-123, 2013 | 218 | 2013 |
| Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis A Beloqui, R Coco, M Alhouayek, MÁ Solinís, A Rodríguez-Gascón, ... International journal of pharmaceutics 454 (2), 775-783, 2013 | 149 | 2013 |
| Self-nano-emulsifying drug-delivery systems: From the development to the current applications and challenges in oral drug delivery AB Buya, A Beloqui, PB Memvanga, V Préat Pharmaceutics 12 (12), 1194, 2020 | 138 | 2020 |
| Overcoming the intestinal barrier: a look into targeting approaches for improved oral drug delivery systems Y Xu, N Shrestha, V Préat, A Beloqui Journal of controlled release 322, 486-508, 2020 | 125 | 2020 |
| Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier A Beloqui, A des Rieux, V Préat Advanced drug delivery reviews 106, 242-255, 2016 | 112 | 2016 |
| An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers Y Xu, N Shrestha, V Préat, A Beloqui Advanced Drug Delivery Reviews 175, 113795, 2021 | 105 | 2021 |
| Dextran–protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs A Beloqui, MÁ Solinís, A des Rieux, V Préat, A Rodríguez-Gascón International journal of pharmaceutics 468 (1-2), 105-111, 2014 | 96 | 2014 |
| Nanoparticle transport across in vitro olfactory cell monolayers O Gartziandia, SP Egusquiaguirre, J Bianco, JL Pedraz, M Igartua, ... International journal of pharmaceutics 499 (1-2), 81-89, 2016 | 94 | 2016 |
| Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs A Beloqui, A del Pozo-Rodríguez, A Isla, A Rodríguez-Gascón, MÁ Solinís Journal of Drug Delivery Science and Technology 42, 144-154, 2017 | 91 | 2017 |
| A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease A Beloqui, PB Memvanga, R Coco, S Reimondez-Troitino, M Alhouayek, ... Colloids and Surfaces B: Biointerfaces 143, 327-335, 2016 | 89 | 2016 |
| A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation A Beloqui, DJ Brayden, P Artursson, V Préat, A des Rieux nature protocols 12 (7), 1387-1399, 2017 | 75 | 2017 |
| Surface modification of lipid-based nanoparticles Y Xu, T Fourniols, Y Labrak, V Préat, A Beloqui, A des Rieux ACS nano 16 (5), 7168-7196, 2022 | 62 | 2022 |
| Reformulating cyclosporine A (CsA): More than just a life cycle management strategy M Guada, A Beloqui, MNVR Kumar, V Préat, M del Carmen Dios-Viéitez, ... Journal of controlled release 225, 269-282, 2016 | 59 | 2016 |
| Biodistribution of nanostructured lipid carriers (NLCs) after intravenous administration to rats: influence of technological factors A Beloqui, MA Solinís, A Delgado, C Evora, A del Pozo-Rodríguez, ... European journal of pharmaceutics and biopharmaceutics 84 (2), 309-314, 2013 | 57 | 2013 |
| Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution A Beloqui, MÁ Solinís, A Delgado, C Évora, A Isla, A Rodríguez-Gascón Journal of microencapsulation 31 (1), 1-8, 2014 | 51 | 2014 |
| Oral delivery of oleuropein-loaded lipid nanocarriers alleviates inflammation and oxidative stress in acute colitis A Huguet-Casquero, Y Xu, E Gainza, JL Pedraz, A Beloqui International journal of pharmaceutics 586, 119515, 2020 | 49 | 2020 |
| The interaction of protamine nanocapsules with the intestinal epithelium: a mechanistic approach LN Thwala, A Beloqui, NS Csaba, D González-Touceda, S Tovar, ... Journal of controlled release 243, 109-120, 2016 | 49 | 2016 |
| Novel strategy for oral peptide delivery in incretin-based diabetes treatment Y Xu, M Van Hul, F Suriano, V Préat, PD Cani, A Beloqui Gut 69 (5), 911-919, 2020 | 48 | 2020 |
